Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

sanofi-aventis (malaysia) sdn. bhd. - insulin glargine -

Israel - English - Ministry of Health

sanofi israel ltd - insulin glargine - solution for injection - insulin glargine 100 u/ml - treatment of adult and pediatric patients, 6 years and over, with type 1 diabetes mellitus or adults patients with type 2 diabetes mellitus who require basal (long acting) insulin for the control of hyperglycemia.

Singapore - English - HSA (Health Sciences Authority)

duopharma (singapore) pte ltd - insulin glargine - injection, solution - insulin glargine 100 iu/ml

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - insulin aspart, quantity: 3.5 mg/ml - injection, solution - excipient ingredients: metacresol; phenol; polysorbate 20; sodium hydroxide; hydrochloric acid; water for injections; zinc chloride; sodium chloride - for the treatment of diabetes mellitus

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

شركة ألفه للأدوية - ulfa pharma co. - insulin glargine 100 iu/ml - 100 iu/ml

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - insulin aspart 100 u/ml (3.5 mg/ml) - solution for injection - 100 u/ml - active: insulin aspart 100 u/ml (3.5 mg/ml) excipient: hydrochloric acid metacresol phenol polysorbate 20 sodium chloride sodium hydroxide water for injection zinc chloride - treatment of diabetes mellitus